Home alone – depression highest for those living alone

 

London, UK (March 23, 2012) – The number of people living on their own has doubled, over the last three decades, to one in three in the UK and US. New research published in BioMed Central’s open access journal BMC Public Health shows that the risk of depression, measured by people taking antidepressants, is almost 80% higher for those living alone compared to people living in any kind of social or family group.

 

For women a third of this risk was attributable to sociodemographic factors, such as lack of education and low income. For men the biggest contributing factors included poor job climate, lack of support at the work place or in their private lives, and heavy drinking.

 

It is known that living alone can increase the risk of mental health problems for the elderly, and for single parents, but little is known about the effects of isolation on working-age people. Researchers in Finland followed 3500 working-aged men and women for seven years and compared their living arrangements with psychosocial, sociodemographic, and health risk factors, including smoking, heavy drinking and low physical activity, to antidepressant use. Information on antidepressant medication was taken from the National Prescription Register.

 

Dr Laura Pulkki-Råback, who conducted the research at the Finnish Institute of Occupational Health, explained, "Our study shows that people living alone have an increased risk of developing depression. Overall there was no difference in the increased risk of depression by living alone for either men or women. Poor housing conditions (especially for women) and a lack of social support (particularly for men) were the main contributory factors to this increased risk."

 

She continued, "This kind of study usually underestimates risk because the people who are at the most risk tend to be the people who are least likely to complete the follow up. We also were not able to judge how common untreated depression was."

 

While this study clearly identifies some of the factors which increase the risk of depression for people who live alone, over half the increase in risk is still unexplained. The researchers suggest that this may be due to feelings of alienation from society, lack of trust, or difficulties arising from critical life events. All these factors need to be addressed in order to begin understanding and reducing the incidence of depression amongst working age people.

 

 

Notes to Editors 

  1. Living alone and antidepressant medication use: a prospective study in a working-age population
    Laura Pulkki-Raback, Mika Kivimaki, Kirsi Ahola, Kaisla Joutsenniemi, Marko Elovainio, Helena Rossi, Sampsa Puttonen, Seppo Koskinen, Erkki Isometsa, Jouko Lonnqvist and Marianna Virtanen
    BMC Public Health (in press)
  2. BMC Public Health is an open access, peer-reviewed journal that considers articles on the epidemiology of disease and the understanding of all aspects of public health. The journal has a special focus on the social determinants of health, the environmental, behavioral, and occupational correlates of health and disease, and the impact of health policies, practices and interventions on the community.
  3. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector

 


 

BioMed Central (http://www.biomedcentral.com/), 23.03.2012 (tB).

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung